Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.052 | 0.7 |
mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.061 | 0.7 |
mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |